Publications

Stress journal


A. Refereed Papers

1.       Fink, G., Nallar, R. & Worthington, W.C. Jr. (1967) The demonstration of luteinizing hormone releasing factor in hypophysial portal blood of pro-oestrous and hypophysectomized rats. J. Physiol. 191 407-416.

2.       Fink, G. (1967) Nature of luteinizing hormone releasing factor in hypophysial portal blood.  Nature 215 159-161.

3.       Brown-Grant, K., El Kabir, D.J. & Fink, G. (1968) The effect of mating on pituitary luteinizing hormone and thyrotrophic hormone content in the female rabbit.  J. Endocrinol. 41 91-94.

4.       Fink, G. & Harris, G.W. (1970) The luteinizing hormone releasing activity of extracts of blood from the hypophysial portal vessels of rats.  J. Physiol. 208 221-241.

5.       Fink, G., Smith, J.R. & Tibballs, J. (1971) Corticotrophin releasing factor in hypophysial portal blood of rats.  Nature 203 467-468.

6.       Fink, G. & Smith, G.C. (1971) Ultrastructural features of the developing hypothalamo-hypophysial axis in the rat: a correlative study.  Z. Zellforsch. Mikrosk. Anat. 119 208-226.

7.       Fink, G. & Schofield, G.C. (1971) Experimental studies on the innervation of the ovary in cats.  J. Anat. 109 115-126.

8.       Smith, G.C. & Fink, G. (1972) Experimental studies on the origin of monoamine containing fibres in the hypothalamo-hypophysial complex of the rat.  Brain Res. 43 37-51.

9.       Burger, H.G., Fink, G. & Lee, V.W.K. (1972) Luteinizing hormone releasing factor in ultrafiltrates of blood collected from the pituitary stalk of ovariectomized rats and rats subjected to electrical stimulation of the preoptic area.  J. Endocrinol. 54 227‑237.

10.     Fink, G., Smith, G.C., Tibballs, J. & Lee, V.W.K. (1972) LRF and CRF activity in subcellular fractions of bovine median eminence.  Nature New Biol 239 57-59.

11.     Aiyer, M.S., Fink, G. & Greig, F. (1974) Changes in sensitivity of the pituitary gland to luteinizing hormone releasing factor during the oestrous cycle of the rat. J. Endocrinol. 60 47-64.

12.     Aiyer, M.S. & Fink, G. (1974) The role of sex steroid hormones in modulating the responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in the female rat.  J. Endocrinol. 62 553-572.

13.     Aiyer, M.S., Chiappa, S.A. & Fink, G. (1974) A priming effect of luteinizing hormone releasing factor on the anterior pituitary gland in the female rat.  J. Endocrinol. 62 573-588.

14.     Fink, G. & Aiyer, M.S. (1974) Gonadotrophin secretion after electrical stimulation of the preoptic area during the oestrous cycle of the rat.  J. Endocrinol. 62 589-604.

15.     Fink, G., Gennser, G., Lieldholm, P., Thorell, J. & Mulder, J. (1974) Comparison of plasma levels of luteinizing hormone releasing hormone (LH-RH) in human males after intravenous or intranasal administration.  J. Endocrinol. 63 351-360.

16.     Fink, G. (1975) The responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in rats exposed to constant light.  J. Endocrinol. 65 439-445.

17.     Brown-Grant, K., Fink, G., Greig, F. & Murray, M.A.F. (1975) Altered sexual development in male rats after oestrogen administration during the neonatal period.  J. Reprod. Fertil. 44 25-42.

18.     Fink, G., Smith, G.C., McMaster, R., Osborne, L.W. & Chiappa, S.A. (1975) The catecholamine-containing tubero-infundibular system and the control of luteinizing hormone release in the rabbit.  Brain Res. 89 71-80.

19.     Fink, G., Smith, G.C. & Augee, M.L. (1975) Histochemical, ultrastructural and hormonal studies on the pars distalis of the echidna (Tachyglossus aculeatus).  Cell Tissue Res. 159 531-540.

20.     Jamieson, M.G. & Fink, G. (1976) Parameters of electrical stimulation of the medial preoptic area for release of gonadotrophins in male rats.  J. Endocrinol. 68 57‑70.

21.     Fink, G. & Jamieson, M.G. (1976) Immunoreactive luteinizing hormone releasing factor in rat pituitary stalk blood: effects of electrical stimulation of the medial preoptic area.  J. Endocrinol. 68 71-87.

22.     Sarkar, D.K., Chiappa, S.A., Fink, G. & Sherwood, N.M. (1976) Gonadotropin-releasing hormone surge in pro-oestrous rats.  Nature 264 461-463.

23.     Bird, E.D., Chiappa, S.A. & Fink, G. (1976) Brain immunoreactive gonadotropin releasing hormone in Huntington’s chorea and in normal subjects.  Nature 260 536-538.

24.     Fink, G., Chiappa, S.A. & Aiyer, M.S. (1976) Priming effect of luteinizing hormone releasing factor elicited by preoptic stimulation and by intravenous infusion and multiple injections of the synthetic decapeptide.  J. Endocrinol. 69 359-372.

25.     Pickering, A. & Fink, G. (1976) Priming effect of luteinizing hormone releasing factor; in vitro and in vivo evidence consistent with its dependence upon protein and RNA synthesis.  J. Endocrinol. 69 373-379.

26.     Pickering, A. & Fink, G. (1976) Priming effect of luteinizing hormone releasing factor: in vitro studies with raised potassium ion concentrations.  J. Endocrinol. 69 453‑454.

27.     Sherwood, N.M., Chiappa, S.A. & Fink, G. (1976) Immunoreactive luteinizing hormone releasing factor in pituitary stalk blood from female rats; sex steroid modulation of response to electrical stimulation of preoptic area or median eminence.  J. Endocrinol. 70 501-511.

28.     Chiappa, S.A. & Fink, G. (1977) Hypothalamic luteinizing hormone releasing factor and corticotrophin releasing activity in relation to pituitary and plasma hormone levels in male and female rats.  J. Endocrinol. 72 195‑210.

29.     Chiappa, S.A. & Fink, G. (1977) Releasing factor and hormonal changes in the hypothalamic-pituitary-gonadotrophin and  -adrenocorticotrophin systems before and after birth and puberty in male, female and androgenized female rats.  J. Endocrinol. 72 211-224.

30.     Fink, G. & Henderson, S.R. (1977) Steroids and pituitary responsiveness in female, androgenized female and male rats.  J. Endocrinol. 73 157-164.

31.     Fink, G. & Henderson, S.R. (1977) Site of modulatory action of oestrogen and progesterone on gonadotrophin response to luteinizing hormone releasing factor.  J. Endocrinol. 73 165-170.

32.     Chiappa, S.A., Fink, G. & Sherwood, N.M. (1977) Immunoreactive luteinizing hormone releasing factor (LRF) in pituitary stalk plasma from female rats: effects of stimulating diencephalon, hippocampus and amygdala.  J. Physiol. 267 625‑640.

33.     Henderson, S.R., Baker, C. & Fink, G. (1977) Oestradiol-17ß and pituitary responsiveness to luteinizing hormone releasing factor in the rat; a study using rectangular pulses of oestradiol-17ß monitored by non-chromatographic radioimmunoassay.  J. Endocrinol. 73 441-453.

34.     Henderson, S.R., Baker, C. & Fink, G. (1977) Effect of oestradiol-17ß exposure on the spontaneous secretion of gonadotrophins in chronically gonadectomized rats.  J. Endocrinol. 73 455-462.

35.     Blessing, W.W., Costa, M., Geffen, L.B., Rush, R.A. & Fink, G. (1977) Immune lesions of noradrenergic neurones in rat central nervous system produced by antibodies to dopamine-ß-hydroxylase.  Nature 267 368-369.

36.     Cattanach, B.M., Iddon, C.A., Charlton, H.M., Chiappa, S.A. & Fink, G. (1977) Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism.  Nature 269 338-340.

37.     Pickering, A.J.M.C. & Fink, G. (1977) A priming effect of luteinizing hormone releasing factor with respect to release of follicle stimulating hormone in vitro and in vivoJ. Endocrinol. 75 155‑159.

38.     Sarkar, D.K. & Fink, G. (1979) Effects of gonadal steroids on output of luteinizing hormone releasing factor into pituitary stalk blood in the female rat.  J. Endocrinol. 80 303-313.

39.     Pickering, A.J.M.C. & Fink, G. (1979) Priming effect of luteinizing hormone releasing factor in vitro: role of protein synthesis, contractile elements, Ca2+ and cyclic AMP.  J. Endocrinol. 81 223-234.

40.     Pickering, A.J.M.C. & Fink, G. (1979) Do hypothalamic regulatory factors other than LH-RF exert a priming effect?  J. Endocrinol. 81 235-238.

41.     Pickering, A.J.M.C. & Fink, G. (1979) Variation in size of the ‘readily releasable pool’ of luteinizing hormone during the oestrous cycle of the rat.  J. Endocrinol. 83 53-59.

42.     Sarkar, D.K. & Fink, G. (1979) Mechanism of the first spontaneous gonadotrophin surge and that induced by pregnant mare serum and effects of neonatal androgen.  J. Endocrinol. 83 339-354.

43.     Sherwood, N.M. & Fink, G. (1980) Effect of ovariectomy and adrenalectomy on luteinizing-hormone releasing hormone in pituitary stalk blood from female rats.  Endocrinology 106 363‑367.

44.     Iddon, C.A., Charlton, H.M. & Fink, G. (1980) Gonadotrophin release in hypogonadal and normal mice after electrical stimulation of the median eminence or injection of luteinizing hormone releasing hormone.  J. Endocrinol. 85 105-110.

45.     Sarkar, D.K. & Fink, G. (1980) Luteinizing hormone releasing factor in pituitary stalk plasma from long-term ovariectomized rats: effects of steroids.  J. Endocrinol. 86 511-524.

46.     Sherwood, N.M., Chiappa, S.A., Sarkar, D.K. & Fink, G. (1980) Gonadotropin-releasing hormone (GnRH) in pituitary stalk blood from proestrous rats: effects of anesthetics and relationship between stored and released GnRH and luteinizing hormone.  Endocrinology 107 1410-1417.

47.     Fink, G., Malnick, S., Sarkar, D.K. & Twine, M. (1980) Sex difference in the anaesthetic dose of a steroid anaesthetic Althesin in the rat; effect of oestradiol-17ß.  J. Physiol. 307 27-28.

48.     Sarkar, D.K. & Fink, G. (1981) Gonadotropin-releasing hormone surge: possible modulation through postsynaptic alpha-adrenoreceptors and two pharmacologically distinct dopamine receptors.  Endocrinology 108 862‑867.

49.     Speight, A., Popkin, R., Watts, A.G. & Fink, G. (1981) Oestradiol-17ß increases pituitary responsiveness by a mechanism that involves the release and the priming effect of luteinizing hormone releasing factor.  J. Endocrinol. 88 301-308.

50.     Sarkar, D.K., Smith, G.C. & Fink, G. (1981) Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.  Brain Res. 213 335-349.

51.     Speight, A. & Fink, G. (1981) Changes in responsiveness of dispersed pituitary cells to luteinizing hormone releasing hormone at different times of the oestrous cycle of the rat.  J. Endocrinol. 89 129-134.

52.     Watts, A.G. & Fink, G. (1981) Constant light blocks diurnal but not pulsatile release of luteinizing hormone in the ovariectomized rat.  J. Endocrinol. 89 141-146.

53.     Watts, A.G. & Fink, G. (1981) Effects of short-term constant light on the proestrous luteinizing hormone surge and pituitary responsiveness in the female rat.  Neuroendocrinology 33 176‑180.

54.     Meidan, R., Fink, G. & Koch, Y. (1981) Ontogeny of the sensitizing effect of oestradiol and luteinizing hormone releasing hormone on the anterior pituitary of the female rat.  J. Endocrinol. 91 347-351.

55.     Speight, A. & Fink, G. (1981) Comparison of steroid and LH-RH effects on the responsiveness of hemipituitary glands and dispersed pituitary cells.  Mol. Cell. Endocrinol. 24 267-281.

56.     Fink, G., Koch, Y. & Ben Aroya, N. (1982) Release of thyrotropin releasing hormone into hypophysial portal blood is high relative to other neuropeptides and may be related to prolactin secretion.  Brain Res. 243 186-189.

57.     Fink, G., Sarkar, D.K., Dow, R.C., Dick, H., Borthwick, N., Malnick, S. & Twine, M. (1982) Sex difference in response to alphaxalone anaesthesia may be oestrogen dependent.  Nature 298 270‑272.

58.     Versi, E., Chiappa, S.A., Fink, G. & Charlton, H.M. (1982) Effect of copulation on the hypothalamic content of gonadotrophic hormone-releasing hormone in the vole, Microtus agrestisJ. Reprod. Fertil. 64 491-494.

59.     MacInnes, D.G., Laszlo, I., MacIntyre, I. & Fink, G. (1982) Salmon calcitonin in lizard brain: a possible neuroendocrine transmitter.  Brain Res. 251 371‑373.

60.     Fink, G., Sheward, W.J. & Charlton, H.M. (1982) Priming effect of luteinizing hormone releasing hormone in the hypogonadal mouse.  J. Endocrinol. 94 283-287.

61.     Smith, G.C., Sheward, W.J. & Fink, G. (1982) Effect of 6-hydroxydopamine lesions of the median eminence and neurointermediate lobe on the secretion of pituitary hormones in the male rat.  Brain Res. 246 330-333.

62.     McDowell, I.F.W., Morris, J.F., Charlton, H.M. & Fink, G. (1982) Effects of luteinizing hormone releasing hormone on the gonadotrophs of hypogonadal (hpg) mice.  J. Endocrinol. 95 331‑342.

63.     Whalley, L.J., Rosie, R., Dick, H., Levy, G., Watts, A.G., Sheward, W.J., Christie, J.E. & Fink, G. (1982) Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.  Lancet II 1064-1068.

64.     Whalley, L.J., Robinson, I.C.A.F. & Fink, G. (1982) Oxytocin and neurophysin in post-partum mania.  Lancet II 387. (Letter)

65.     Versi, E., Chiappa, S.A., Fink, G. & Charlton, H.M. (1983) Pineal influences hypothalamic Gn-RH content in the vole, Microtus agrestisJ. Reprod. Fertil67 365-368.

66.     Millar, R.P., Sheward, W.J., Wegener, I. & Fink, G. (1983) Somatostatin-28 is an hormonally active peptide secreted into hypophysial portal vessel blood.  Brain Res. 260 334-337.

67.     Yates, C.M., Harmar, A.J., Rosie, R., Sheward, J., Simpson, J., Maloney, A.F.J., Gordon, A. & Fink, G. (1983) Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of Alzheimer-type dementia and Down’s syndrome.  Brain Res258 45-52.

68.     Curtis, A. & Fink, G. (1983) A high molecular weight precursor of luteinizing hormone releasing hormone from rat hypothalamus.  Endocrinology 112 390‑392.

69.     MacInnes, D.G., Green, D.K., Harmar, A.J., Nairn, E.G. & Fink, G. (1983) Neuropeptide-receptor interactions studied with the aid of fluorescence activated cell sorting and video intensification microscopy.  J. Neurosci. Methods 7 309-316.

70.     MacInnes, D.G., Green, D.K., Harmar, A., Nairn, E.G. & Fink, G. (1983) Neuroendocrine receptor-ligand binding using quantitative video-intensification microscopy and fluorescence-activated cell sorting.  Q. J. Exp. Physiol. 68 463‑474.

71.     Tansey, E.M., Arbuthnott, G.W., Fink, G. & Whale, D. (1983) Oestradiol-17ß increases the firing rate of antidromically identified neurones of the rat neostriatum.  Neuroendocrinology 37 106-110.

72.     Sutherland, R.C., Martin, M.J., McQueen, J.K. & Fink, G. (1983) Water deprivation results in increased 2-deoxyglucose uptake by the paraventricular neurones as well as pars nervosa in Wistar and Brattleboro rats.  Brain Res. 271 101-108.

73.     Mitchell, R., Grieve, G., Dow, R. & Fink, G. (1983) Endogenous GABA receptor ligands in hypophysial portal blood.  Neuroendocrinology 37 169-176.

74.     Charlton, H.M., Halpin, D.M.G., Iddon, C., Rosie, R., Levy, G., McDowell, I.F.W., Megson, A., Morris, J.F., Bramwell, A., Speight, A., Ward, B.J., Broadhead, J., Davey-Smith, G. & Fink, G. (1983) The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse.  Endocrinology 113 535-544.

75.     Charlton, H.M., Speight, A., Halpin, D.M.G., Bramwell, A., Sheward, W.J. & Fink, G. (1983) Prolactin measurements in normal and hypogonadal (hpg) mice: developmental and experimental studies.  Endocrinology 113 545‑548.

76.     Sutherland, R.C. & Fink, G. (1983) The milk ejection pathway in brain studied with the 2‑deoxyglucose method.  Brain Res. 273 291-296.

77.     Sheward, W.J., Harmar, A.J., Fraser, H.M. & Fink, G. (1983) Thyrotropin-releasing hormone in rat pituitary stalk blood and hypothalamus: studies with high performance liquid chromatography.  Endocrinology 113 1865‑1869.

78.     Sarkar, D.K., Gottschall, P.E., Meites, J., Horn, A., Dow, R.C., Fink, G. & Cuello, A.C. (1983) Uptake and release of [3H]dopamine by the median eminence: evidence for presynaptic dopaminergic receptors and for dopaminergic feedback inhibition.  Neuroscience 10 821-830.

79.     McQueen, J.K., Martin, M.J. & Fink, G. (1984) Comparison of the effects of Althesin and sodium pentobarbitone on the regional uptake of 2-deoxyglucose by the brain and pituitary gland of the rat: selective effects on pars intermedia.  Neuroendocrinology 38 237-242.

80.     Charlton, H.M., Chiappa, S.A., Fink, G., Grocock, C.A. & Versi, E. (1983) Hypothalamic gonadotropin-releasing hormone and pituitary luteinizing hormone contents in the male vole (Microtus agrestis) in the field during the breeding and non-breeding seasons.  Can. J. Zool. 61 2405-2410.

81.     Curtis, A., Lyons, V. & Fink, G. (1983) The human hypothalamic LHRH precursor is the same size as that in rat and mouse hypothalamus.  Biochem. Biophys. Res. Commun. 117 872-877.

82.     Sheward, W.J., Benoit, R. & Fink, G. (1984) Somatostatin-28(1-12)-like immunoreactive substance is secreted into hypophysial portal vessel blood in the rat.  Neuroendocrinology 38 88-90.

83.     Fink, G., Sheward, W.J. & Plant, T.M. (1984) The hypogonadal mouse pituitary contains bioactive LH.  J. Reprod. Fertil. 70 277-280.

84.     Prowse, C.V., Dow, R.C. & Fink, G. (1984) A hypothalamic-pituitary system that stimulates the release of plasminogen activator in the rat.  Brain Res. 299 133‑138.

85.     Sutherland, R.C., Fink, G. & Charlton, H.M. (1984) Effect of mating on the metabolic activity of the brain and pituitary gland assessed by [14C]2-deoxyglucose in a reflex ovulator, the vole (microtus agrestis).  Brain Res. 311 317-322.

86.     Brar, A.K. & Fink, G. (1984) Effects of acute administration of 2-hydroxylated metabolites of oestrogens on LH and prolactin secretion in male and female prepubertal rats.  J. Endocrinol. 103 317-325.

87.     Watts, A.G. & Fink, G. (1984) Pulsatile luteinizing hormone release, and the inhibitory effect of estradiol-17ß in gonadectomized male and female rats: effects of neonatal androgen or exposure to constant light.  Endocrinology 115 2251‑2259.

88.     Brar, A.K., McNeilly, A.S. & Fink, G. (1985) Effects of hyperprolactinaemia and testosterone on the release of LH-releasing hormone and the gonadotrophins in intact and castrated rats.  J. Endocrinol. 104 35-43.

89.     Whalley, L.J., Christie, J.E., Bennie, J., Dick, H., Blackburn, I.M., Blackwood, D., Sanchez Watts, G. & Fink, G. (1985) Selective increase in plasma luteinising hormone concentrations in drug free young men with mania.  Brit. Med. J. 290 99-102.

90.     Horn, A.M., Fraser, H.M. & Fink, G. (1985) Effects of antiserum to thyrotrophin-releasing hormone on the concentrations of plasma prolactin, thyrotrophin and LH in the pro-oestrous rat.  J. Endocrinol. 104 205-209.

91.     Horn, A.M., Robinson, I.C.A.F. & Fink, G. (1985) Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal and Brattleboro rats.  J. Endocrinol. 104 211-224.

92.     Horn, A.M., & Fink, G. (1985) Parachlorophenylalanine blocks the spontaneous pro-oestrous surge of prolactin as well as LH and affects the secretion of oestradiol-17ß.  J. Endocrinol. 104 415‑418.

93.     Horn, A.M. & Fink, G. (1985) Effects of 5-hydroxytryptamine uptake blockers on the release of LH and prolactin in several different experimental steroid models in the rats.  J. Endocrinol. 104 397-406.

94.     Watts, A.G. & Fink, G. (1985) Effects of progesterone on the pituitary responsiveness to, and priming effect of luteinizing hormone releasing hormone in female rats exposed to constant light.  Neuroendocrinology 40 152-159.

95.     Yates, C.M., Fink, G., Bennie, J.G., Gordon, A., Simpson, J. & Eskay, R.L. (1985) Neurotensin immunoreactivity in post-mortem brain is increased in Down’s syndrome but not in Alzheimer-type dementia.  J. Neurol. Sci. 67 327-335.

96.     Curtis, A., Lyons, V. & Fink, G. (1985) The priming effect of LH-releasing hormone: effects of cold and involvement of new protein synthesis.  J. Endocrinol. 105 163-167.

97.     Simpson, J., Williamson, I.J. & Fink, G. (1985) Choline acetyltransferase activity in the pars distalis, preoptic area and striatum during the rat estrous cycle.  Neuroendocrinology 40 444‑449.

98.     Sheward, W.J., Watts, A.G., Fink, G. & Smith, G.C. (1985) Effects of intravenously administered 6‑hydroxydopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat.  Neurosci. Lett. 55 141-144.

99.     Sheward, W.J., Fraser, H.M. & Fink, G. (1985) Effect of immunoneutralization of thyrotrophin-releasing hormone on the release of thyrotrophin and prolactin during suckling or in response to electrical stimulation of the hypothalamus in the anaesthetized rat.  J. Endocrinol. 106 113‑119.

100.   Lewis, C.E., Morris, J.F. & Fink, G. (1985) The role of microfilaments in the priming effect of LH‑releasing hormone: an ultrastructural study using cytochalasin B.  J. Endocrinol. 106 211‑218.

101.   Sutherland, R.C., Fink, G. & Morris, J.F. (1985) Effects of water deprivation and deamino [8‑D‑arginine] vasopressin on [14C] 2-deoxyglucose uptake by the hypothalamo-hypophysial system in mice with hereditary nephrogenic diabetes insipidus.  Brain Res. 340 297-303.

102.   Brar, A.K., Fink, G., Maletti, M. & Rostene, W. (1985) Vasoactive intestinal peptide in rat hypophysial portal blood: effects of electrical stimulation of various brain areas, the oestrous cycle and anaesthetics.  J. Endocrinol. 106 275-280.

103.   Sheward, W.J., Harmar, A.J. & Fink, G. (1985) LH-RH in the rat and mouse hypothalamus and rat hypophysial portal blood: confirmation of identity by high performance liquid chromatography.  Brain Res. 345 362-365.

104.   Stanley, H.F. & Fink, G. (1985) The short-term effects of testosterone on brain protein synthesis in 4-day-old rats: an electrophoretic study of proteins following intraventricular injection of [35S]‑methionine.  Brain Res. 358 241-248.

105.   Hussey, S., Yates, C.M. & Fink, G. (1986) Fluorescence activated cell sorting (FACS) as a separation method for neurofibrillary tangles in Alzheimer’s disease.  J. Neurosci. Methods 16 1‑8.

106.   Christie, J.E., Whalley, L.J., Dick, H., Blackwood, D.H.R., Blackburn, I.M. & Fink, G. (1986) Raised plasma cortisol concentrations a feature of drug-free psychotics and not specific for depression.  Br. J. Psychiatry 148 58‑65.

107.   Lewis, C.E., Morris, J.F., Fink, G. & Johnson, M. (1986) Changes in the granule population of gonadotrophs of hypogonadal (hpg) and normal female mice associated with the priming effect of LH-releasing hormone in vitroJ. Endocrinol. 109 35-44.

108.   Whalley, L.J., Borthwick, N., Copolov, D., Dick, H., Christie, J.E. & Fink, G. (1986) Glucocorticoid receptors and depression.  Br. Med. J. 292 859-861.

109.   Stanley, H.F., Borthwick, N.M. & Fink, G. (1986) Brain protein changes during development and sexual differentiation in the rat.  Brain Res. 370 215-222.

110.   Stanley, H.F. & Fink, G. (1986) Synthesis of specific brain proteins is influenced by testosterone at mRNA level in the neonatal rat.  Brain Res. 370 223-231.

111.   Yates, C.M., Laszlo, I., Fink, G., Hastings, I., Boyd, J. & James, K. (1986) Monoclonal antibodies to human hypoglossal nucleus which stain neurons and astrocytes in normal brains and brains from cases of Alzheimer-type dementia.  Neuroscience 18 183-191.

112.   Halpin, D.M.G., Jones, A., Fink, G. & Charlton, H.M. (1986) Postnatal ovarian follicle development in hypogonadal (hpg) and normal mice and associated changes in the hypothalamic-pituitary ovarian axis.  J. Reprod. Fertil. 77 287-296.

113.   Lewis, C.E., Fink, G., Dow, R.C. & Morris, J.F. (1986) Hyperprolactinaemia induced by pituitary isografts suppresses the priming effect of LH-releasing hormone in normal and hypogonadal mice.  Neuroendocrinology 43 584‑589.

114.   Fink, G. (1986) The external layer of the median eminence: a neurovascular synapse.  Neurochem. Int. 9 141-153.

115.   Simpson, J., Boyd, J.E., Yates, C.M., Christie, J.E., Fink, G., James, K. & Gordon, A. (1986) Autoantibodies to Alzheimer and normal brain structures from virus-transformed lymphocytes.  J. Neuroimmunol. 13 1‑8.

116.   Harmar, A.J., Armstrong, A., Pascall, J.C., Chapman, K., Rosie, R., Curtis, A., Going, J., Edwards, C.R.W. & Fink, G. (1986) cDNA sequence of human ß-preprotachykinin, the common precursor to substance P and neurokinin A.  FEBS Lett. 208 67-72.

117.   Stanley, H.F., Curtis, A., Sheward, W.J., Roberts, J.L. & Fink, G. (1986) Prolactin messenger ribonucleic acid levels in the normal and hypogonadal mouse pituitary gland.  Endocrinology 119 2422-2426.

118.   Whalley, L.J., Christie, J.E., Bennie, J., Dick, H., Sloan-Murphy, J. & Fink, G. (1987) Elevated plasma luteinizing hormone concentrations, cryptorchidism and mania.  Psychoneuroendocrinology 12 73-77.

119.   Christie, J.E., Whalley, L.J., Bennie, J., Dick, H., Blackburn, I.M., Blackwood, D.H.R. & Fink, G. (1987) Characteristic plasma hormone changes in Alzheimers disease.  Br. J. Psychiatry 150 674-681.

120.   Whalley, L.J., Kutcher, S., Blackwood, D.H.R., Bennie, J., Dick, H. & Fink, G. (1987) Increased plasma LH in manic-depressive illness: evidence of a state-independent abnormality.  Br. J. Psychiatry 150 682-684.

121.   Whalley, L.J., Eagles, J.M., Bowler, G.M.R., Bennie, J.G., Dick, H.R., McGuire, R.J. & Fink, G. (1987) Selective effects of ECT on hypothalamic-pituitary activity.  Psychol. Med. 17 319-328.

122.   Simpson, J., Milne, I.H., Gardner, J.O., Yates, C.M., James, K. & Fink, G. (1987) Antibodies to normal and Alzheimer human brain structures from non-immunised mice of various ages.  FEBS Lett. 217 62-64.

123.   Blackburn, I.M., Whalley, L.J., Christie, J.E., Shering, A., Foggo, M., Bennie, J., Farrer, D., Watts, G., Wilson, H. & Fink, G. (1987) Mood, cognition and cortisol: their temporal relationships during recovery from depressive illness.  J. Affective Disord. 13 31-43.

124.   Ogier, S-A., Mitchell, R. & Fink, G. (1987) Solubilization of a large molecular weight form of the rat LHRH receptor.  J. Endocrinol. 115 151-159.

125.  Jakubowski, M., Dow, R.C. & Fink, G. (1988) Preoptic-hypothalamic pathways controlling nocturnal prolactin surges, pseudopregnancy, and estrous cyclicity in the rat.  Neuroendocrinology 47 13-19.

126.  Maxwell, R.C., & Fink, G. (1988) The patterns of [14C]2-deoxyglucose uptake in female rat brain produced by electrical stimulation of hypothalamic and limbic brain areas.  Neuroscience 24 241-263.

127.  Maxwell, R.C. & Fink, G. (1988) The connections between the suprachiasmatic, ventrolateral geniculate and raphe nuclei studied by uptake of [14C]2-deoxyglucose.  Neuroscience 24 265‑274.

128.  Johnson, M.S., Mitchell, R. & Fink, G. (1988) The role of protein kinase C in LHRH-induced LH and FSH release and LHRH self-priming in rat anterior pituitary glands in vitroJ. Endocrinol. 116 231-239.

129.  Hunter, R., Dick, H., Christie, J.E., Goodwin, G.M. & Fink, G. (1988) Lymphocyte glucocorticoid receptor binding in depression: normal values following recovery.  J. Affective Disord. 14 155‑159.

130.  McQueen, J.K., Martin, M.J. & Fink, G. (1988) Metabolic mapping of functional activity in the olfactory system of normal and hypogonadal (hpg) mice.  Neuroendocrinology 47 437-443.

131.  Fink, G., Robinson, I.C.A.F. & Tannahill, L.A. (1988) Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.  J. Physiol. 401 329-345.

132.  McQueen, J.K. & Fink, G. (1988) Changes in local cerebral glucose utilization associated with the spontaneous ovulatory surge of luteinizing hormone in the rat.  Neuroendocrinology 47 551‑555.

133.  Robinson, I.C.A.F., Fairhall, K.M., Dow, C.D. & Fink, G. (1988) Neurohypophysial peptides in guinea pig hypophysial portal blood: equimolar release of the carboxyl terminal glycopeptide with arginine vasopressin.  Neuroendocrinology 47 575-581.

134.  Mayes, C.R., Watts, A.G., McQueen, J.K., Fink, G. & Charlton, H.M. (1988) Gonadal steroids influence neurophysin II distribution in the forebrain of normal and mutant mice.  Neuroscience 25 1013-1022.

135.  Fink, G. (1988) Oestrogen and progesterone interactions in the control of gonadotrophin and prolactin secretion.  J. Steroid Biochem. 30 169-178.

136.  Mitchell, R., Johnson, M., Ogier, S-A. & Fink, G. (1988) Facilitated calcium mobilization and inositol phosphate production in the priming effect of LH-releasing hormone in the rat.  J. Endocrinol. 119 293-301.

137.  Simpson, J., Yates, C., Watts, A.G. & Fink, G. (1988) Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type.  Neuropathol. Appl. Neurobiol. 14 381‑393.

138.  Tannahill, L.A., Dow, R.C., Fairhall, K.M., Robinson, I.C.A.F. & Fink, G. (1988) Comparison of adrenocorticotropin control in Brattleboro, Long-Evans and Wistar rats.  Neuroendocrinology 48 650-657.

139.  Stanley, H.F., Lyons, V., Obonsawin, M.C., Bennie, J., Carroll, S., Roberts, J.L. & Fink, G. (1988) Regulation of pituitary ?-subunit, ß-luteinizing hormone and prolactin messenger ribonucleic acid by gonadotropin-releasing hormone and estradiol in hypogonadal mice.  Mol. Endocrinol. 2 1302-1310.

140.  Hunter, R., Gordon, A., McLuskie, R., Wyper, D., Patterson, J., Christie, J.E., Fink, G. & Goodwin, G.M. (1989) Gross regional cerebral hypofunction with normal CT scan in Creutzfeldt-Jakob disease.  Lancet I 214-215.

141.  Thomas, G.B., Cummins, J.T., Smythe, G.A., Gleeson, R.M., Dow, R.C., Fink, G. & Clarke, I.J. (1989) Concentrations of dopamine and noradrenaline in hypophysial portal blood in the sheep and the rat.  J. Endocrinol. 121 141-147.

142.  Christie, J.E., Whalley, L.J., Hunter, R., Bennie, J. & Fink, G. (1989) Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment.  J. Affective Disord. 16 115-120.

143.  Hunter, R., Christie, J.E., Whalley, L.K., Bennie, J., Carroll, S., Dick, H., Goodwin, G.M., Wilson, H. & Fink, G. (1989) Luteinizing hormone responses to luteinizing hormone releasing hormone (LHRH) in acute mania and the effects of lithium on LHRH and thyrotrophin releasing hormone tests in volunteers.  Psychol. Med. 19 69-77.

144.  Mobbs, C., Fink, G., Johnson, M., Welch, W. & Pfaff, D. (1989) Similarity of an estrogen-induced protein and a luteinizing hormone releasing hormone-induced protein.  Mol. Cell. Endocrinol. 62 297-306.

145.  Watts, A.G., Sheward, W.J., Whale, D. & Fink, G. (1989) The effects of knife cuts in the sub-paraventricular zone of the female rat hypothalamus on oestrogen-induced diurnal surges of plasma prolactin and LH, and circadian wheel-running activity.  J. Endocrinol. 122 593-604.

146.  Hajek, M., Meier-Ewert, K., Wirz-Justice, A., Tobler, I., Arendt, J., Dick, H. & Fink, G. (1989) Bright white light does not improve narcoleptic symptoms.  Eur. Arch. Psychiatry Neurol. Sci. 238 203-207.

147.  Whalley, L.J., Christie, J.E., Blackwood, D.H.R., Bennie, J., Dick, H., Blackburn, I.M. & Fink, G. (1989) Disturbed endocrine function in the psychoses 1: disordered homeostasis or disease process?  Br. J. Psychiatry 155 455-461.

148.  Whalley, L.J., Christie, J.E., Blackwood, D.H.R., Bennie, J., Dick, H., Blackburn, I.M. & Fink, G. (1989) Disturbed endocrine function in the psychoses II: discriminant function analysis of multihormone data.  Br. J. Psychiatry 155 462-467.

149.  Hunter, R., McLuskie, R., Wyper, D., Patterson, J., Christie, J.E., Brooks, D.N., McCulloch, J., Fink, G. & Goodwin, G.M. (1989) The pattern of function related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer’s disease and Korsakoff’s psychosis.  Psychol. Med. 19 847‑855.

150.  Goodwin, G.M., Shapiro, C.M., Bennie, J., Dick, H., Carroll, S. & Fink, G. (1989) The neuroendocrine responses and psychological effects of infusion of L-tryptophan in anorexia nervosa.  Psychol. Med. 19 857-864.

151.  Sheward, W.J., Coombes, J.E., Bicknell, R.J., Fink, G. & Russell, J.A. (1990) Release of oxytocin but not corticotrophin-releasing factor-41 into rat hypophysial portal vessel blood can be made opiate dependent.  J. Endocrinol. 124 141-150.

152.  Rosie, R., Thomson, E. & Fink, G. (1990) Oestrogen positive feedback stimulates the synthesis of LHRH in neurones of the rostral diencephalon of the rat.  J. Endocrinol. 124 285-289.

153.  Lim, A., Sheward, W.J., Copolov, D., Windmill, D. & Fink, G. (1990) Atrial natriuretic factor is released into hypophysial portal blood: direct evidence that atrial natriuretic factor may be a neurohormone involved in hypothalamic pituitary control.  J. Neuroendocrinol. 2 15-18.

154.  Mobbs, C.V., Fink, G. & Pfaff, D.W. (1990) HIP-70: A protein induced by estrogen in the brain and LH-RH in the pituitary.  Science 247 1477-1479.

155.  Antoni, F.A., Fink, G. & Sheward, W.J. (1990) Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.  J. Endocrinol. 125 175-183.

156.  McQueen, J.K., Wright, A.K., Arbuthnott, G.W. & Fink, G. (1990) Glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes are increased in the hypothalamus of androgen-insensitive testicular feminized (Tfm) mice.  Neurosci. Lett. 118 77-81.

157.  Girgis, S.I., Yates, C.M., Fink, G. & MacIntyre, I. (1990) Calcitonin gene-related peptide and calcitonin immunoreactivity in brain and spinal cord in Alzheimer-type dementia.  J. Neurol. Sci. 99 69-74.

158.  Mobbs, C.V., Fink, G. & Pfaff, D.W. (1990) HIP-70: An isoform of phosphoinositol-specific phospholipase C-?.  Science 249 566-567.

159.  Christie, J., Hunter, R., Bennie, J., Wilson, H., Carroll, S. & Fink, G. (1990) Reduced plasma oestrogen stimulated neurophysin and delayed response to oestrogen challenge in Alzheimer’s disease.  Psychol. Med. 20 773-777.

160.  Seckl, J.R., Campbell, J.C., Edwards, C.R.W., Christie, J.E., Whalley, L.J., Goodwin, G.M. & Fink, G. (1990) Diurnal variation of plasma corticosterone in depression.  Psychoneuroendocrinology 15, No 5 & 6 485-488.

161.  Seckl, J.R., Dickson, K.L. & Fink, G. (1991) Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression.  J. Neuroendocrinol. 2 911-916.

162.  Sheward, W.J. & Fink, G. (1991) Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.  J. Endocrinol. 129 91-98.

163.  Tannahill, L.A., Sheward, W.J., Robinson, I.C.A.F. & Fink, G. (1991) Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampus.  J. Endocrinol. 129 99‑107.

164.  Shedlack, K.J., Hunter, R., Wyper, D. McLuskie, R., Fink, G. & Goodwin, G. (1991) The pattern of cerebral activity underlying verbal fluency shown by split-dose single photon emission tomography (SPET or SPECT) in normal volunteers.  Psychol. Med. 21 687-696.

165.  Yates, C.M., Fink, G., Bennie, J., Wilson, H., Carroll, S., Harmar, A.J., Hunter, R. & Gordon, A. (1991) Neurohormones in the hypothalamo-hypophysial system in senile dementia of the Alzheimer type.  Dementia 2 78-87.

166.  Sheward, W.J., Lim, A., Alder, B., Copolov, D., Dow, R.C. & Fink, G. (1991) Hypothalamic release of atrial natriuretic factor and ß‑endorphin into rat hypophysial portal plasma: relationship to oestrous cycle and effects of hypophysectomy.  J. Endocrinol. 131 113-125.

167.  Seckl, J.R., Dickson, K.L., Yates, C. & Fink, G. (1991) Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus.  Brain Res. 561 332‑337.

168.  Fink, G., Rosie, R., Sheward, W.J., Thomson, E. & Wilson, H. (1991) Steroid control of central neuronal interactions and function.  J. Steroid Biochem. Molec. Biol. 40 No. 1-3, pp 123-132.

169.  Seckl, J.R. & Fink, G. (1991) Use of in situ hybridization to investigate the regulation of hippocampal corticosteroid receptors by monoamines.  J. Steroid Biochem. Molec. Biol. 40 No. 4-6, pp 685-688.

170.  Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Lim, A.T., Copolov, D.L., Bennie, J., Carroll, S. & Dick, H. (1991) Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivoJ. Endocrinol. 131 R9-R12.

171.  Fink, A.E., Fink, G., Wilson, H., Bennie, J., Carroll, S. & Dick, H. (1992) Lactation, nutrition and fertility and the secretion of prolactin and gonadotrophins in Mopan Mayan women.  J. Biosoc. Sci. 24 35-52.

172.  Yau, J.L.W., Dow, R.C., Fink, G. & Seckl, J.R. (1992) Medial septal cholinergic lesions increase hippocampal mineralocorticoid and glucocorticoid receptor messenger RNA expression.  Brain Res. 577 155-160.

173.  Seckl, J.R. & Fink, G. (1992) Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivoNeuroendocrinology 55 621-626.

174.  Sumner, B.E.H., Rosie, R. & Fink, G. (1992) Relative density of 5‑hydroxytryptamine receptor subtype mRNAs in female rat neuroendocrine brain determined by in situ hybridization histochemistry.  Mol. Cell. Neurosci. 3 215-223.

175.  Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Bennie, J., Carroll, S. & Dick, H. (1992) Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat. J. Endocrinol. 135 37-43.

176.  Rosie, R., Thomson, E., Blum, M., Roberts, J.L. & Fink, G. (1992) Oestrogen positive feedback reduces arcuate proopiomelanocortin messenger ribonucleic acid. J. Neuroendocrinol. 4 625‑630.

177.  Goodwin, G.M., Muir, W.J., Seckl, J.R., Bennie, J., Carroll, S., Dick, H. & Fink, G. (1992) The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls. J. Affective Disord 26 73-84.

178.  McQueen, J.K., Wright, A.K., Arbuthnott, G.W. & Fink, G. (1992) Astrocytes immunoreactive for glial fibrillary acidic protein (GFAP) are increased in the mediobasal hypothalamus in hypogonadal (hpg) mice. Mol. Cell. Neurosci. 3 473-481.

179.  McQueen, J.K., Dow, R.C. & Fink, G. (1992) Gonadal steroids regulate number of astrocytes immunostained for glial fibrillary acidic protein in mouse hippocampus. Mol. Cell. Neurosci. 3 482-486.

180.  Sumner, B.E.H. & Fink, G. (1993) Effects of acute estradiol on 5‑hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain.  Mol. Cell. Neurosci. 4 83-92.

181.  Rosie, R., Wilson, H. & Fink, G. (1993) Testosterone induces an all-or-none, exponential increase in arginine vasopressin mRNA in the bed nucleus of stria terminalis of the hypogonadal mouse.  Mol. Cell. Neurosci. 4 121‑126.

182.  Seckl, J.R., Dow, R.C., Low, S.C., Edwards, C.R.W. & Fink, G. (1993) The 11ß‑hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. J. Endocrinol. 136 471-477.

183.  Seckl, J.R., French, K.L., O’Donnell, D., Meaney, M.J., Nair, N.P.V., Yates, C.M. & Fink, G. (1993) Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer’s disease. Mol. Brain Res. 18 239-245.

184.  Young, A.H., Dow, R.C., Goodwin, G.M. & Fink, G. (1993) The effects of adrenalectomy and ovariectomy on the behavioural and hypothermic responses of rats to 8-hydroxy-2(Di-n-propylamino)tetralin (8-OH-DPAT).  Neuropharmacology 32 653-657.

185.  Riddle, W.J.R., Scott, A.I.F., Bennie, J., Carroll, S. & Fink, G. (1993) Current intensity and oxytocin release after electroconvulsive therapy. Biol Psychiatry 33: 839‑841.

186.  Morrow, J.A., Lutz, E.M., West, K.M., Fink, G. & Harmar, A.J. (1993) Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett. 329: 99‑105.

187.  Lutz, E.M., Sheward, W.J., West, K.M., Morrow, J.A., Fink, G. & Harmar, A.J. (1993) The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334: 3-8.

188.  Goodwin, G.M., Austin, M-P., Curran, S.M., Ross, M., Murray, C., Prentice, N., Ebmeier, K.P., Bennie, J., Carroll, S., Dick, H. and Fink, G. (1993) The elevation of plasma ß-endorphin levels in major depression.  J Affective Disord 29, 281-289.

189.  Turnbull, A.V., Dow, R.C., Hopkins, S.J., White, A., Fink, G. and Rothwell, N.J. (1994) Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat.  Psychoneuroendocrinology 19, 165-178.

190.  Young, A.H., Goodwin, G.M., Dick, H. and Fink, G. (1994) Effects of glucocorticoids on 5‑HT1A presynaptic function in the mouse.  Psychopharmacology 114: 360-364.

191.  Dow, R.C., Williams, B.C., Bennie, J., Carroll, S. and Fink, G. (1994) A central 5-HT2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the rat.  Psychoneuroendocrinology 19: 395-399.

192.  Rosie, R., Sumner, B.E.H. and Fink, G. (1994) An alpha1 adrenergic mechanism mediates estradiol stimulation of LHRH mRNA synthesis and estradiol inhibition of POMC mRNA synthesis in the hypothalamus of the prepubertal female rat.  J. Steroid Biochem. Molec. Biol. 49: 399‑406.

193.  Dow, R.C., Bennie, J. and Fink, G. (1994) Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat.  J. Endocrinol. 142: R1-R4.

194.  Lim, A.T., Dow, R.C., Yang, Z. and Fink, G. (1994) ANP(5-28) is the major molecular species in hypophysial portal blood of the rat.  Peptides 15: 1557-1559.

195.  Fink, G. (1995) The self-priming effect of LHRH: A unique servomechanism and possible cellular model for memory.  Front. Neuroendocrinol. 16: 183-190.

196.  Sumner, B.E.H. and Fink, G. (1995) Estrogen increases the density of 5-HT2A receptors in cerebral cortex and nucleus accumbens in the female rat.  J. Steroid Biochem. Molec. Biol. 54: 15-20.

197.  Ogilvie, A.D., Battersby, S., Bubb, V.J., Fink, G., Harmar, A.J., Goodwin, G.M. and Smith, C.A.D. (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression.  Lancet 347: 731-733.

198.  Fink, G., Sumner, B.E.H., Rosie, R., Grace, O. and Quinn, J.P. (1996) Estrogen control of central neurotransmission: effect on mood, mental state, and memory.  Cell. Mol. Neurobiol. 16: 325-344.

199.  Fink, G. and Sumner B.E.H. (1996) Oestrogen and mental state.  Nature 383: 306.

200.  Battersby, S., Ogilvie, A.D., Smith, C.A.D., Blackwood, D.H.R., Muir, W.J., Quinn, J.P., Fink, G., Goodwin, G.M., Harmar, A.J. (1996) Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder.  Psychiatric Genetics. 6: 177-181.

201. McQueen, J K, Wilson, H and Fink, G. (1997) Estradiol-17ß increases serotonin transporter (SERT) mRNA levels and the density of SERT binding sites in female rat brain.  Mol. Brain Res. 45 (1): 13-23.

202.  Sumner, B.E.H. and Fink, G. (1997) The density of 5-hydroxytryptamine2A receptors in forebrain is increased at pro-estrus in intact female rats.  Neurosci. Lett. 234: 7-10.

203.  Wu, T.J., Pierotti, A.R., Jakubowski, M., Sheward, W.J., Glucksman, M.J., Smith, A.I., King, J.C., Fink, G., and Roberts, J.L. (1997) Endopeptidase EC 3.4.24.15 presence in the rat median eminence and hypophysial portal blood, and its modulation of the luteinizing hormone surge.  J. Neuroendocrinol. 9, 813-822.

204.  Mitchell, R., McCulloch, D., Lutz, E., Johnson, M., MacKenzie, C., Fennell, M., Fink, G., Zhou, W., & Sealfon, S. C. (1998) Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392: 411-414.

205.  Sumner, B.E.H. and Fink, G., (1998) Testosterone as well as estrogen increases serotonin 2A receptor mRNA and binding site densities in the male rat, Mol. Brain Res., 59: 205-214.

206.  Fink, G., Sumner, B.E.H., McQueen, J.K., Wilson, H. and Rosie, R (1998) Sex steroid control of mood, mental state and memory, Clin. Exp. Pharmacol. Physiol., 25: 764-775.

207.  Fink, G., Dow, R.C., McQueen, J.K., Bennie, J.G., and Carroll, S.M. (1998) Serotonergic 5-HT2A receptors important for the oestradiol-induced surge of luteinising hormone-releasing hormone in the rat, J. Neuroendocrinol 1999;11, 63-9

208.  Antoni, F.A., Palkovits, M., Simpson, J., Smith, S.M., Leitch, A.L., Rosie, R., Fink, G. and Paterson, J.M. (1998) Ca2+/Calcineurin-inhibited adenylyl cyclase highly abundant in forebrain regions important for learning and memory, J. Neurosci. 18: 9650-61

209. McQueen JK, Wilson H, Sumner BE, Fink G. (1999) Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Brain Res Mol Brain Res;63: 241-247

210. Fink G, Sumner B, Rosie R, Wilson H, McQueen J (1999). Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res;105: 53-68

211. Sumner BE, Grant KE, Rosie R, Hegele-Hartung C, Fritzemeier KH, Fink G. (1999) Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol Brain Res 73:119-2

212. Lavon I, Sheinin T, Meilin S, Biton E, Weksler A, Efroni G, Bar-Joseph A, Fink G & Avraham A (2003) A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. Mol Pharmacol 64: 1334-41

213. Jüttler E, Potrovita I, Tarabin V, Prinz S, Dong-Si T, Fink G, Schwaninger M.(2004) The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-KB). Neuropharmacology 47:580-592.

214. Sumner BE, Grant KE, Rosie R, Hegele-Hartung C, Fritzemeier KH, Fink G. (2007) Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain, Neurosci Lett 417: 95-99. http://dx.doi.org/10.1016/j.neulet.2007.02.039

215. Attardi B, Scott R, Pfaff D, Fink G. (2007) Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms. J Neuroendocrinol.19:988-1000.

216. Pereira A, Fink G, Sundram S (2009) Clozapine-Induced ERK1 and ERK2 Signaling in Prefrontal Cortex Is Mediated by the EGF Receptor. J Mol Neurosci 39:185-98.

217. Fink G (2011) Stress Controversies: Posttraumatic Stress Disorder, Hippocampal Volume, Gastro-Duodenal Ulceration. J Neuroendocrinol 23: 107–117

218. Pereira A, Sugiharto-Winarno A, Zhang B, Malcolm P, Fink G, Sundram S. (2011) Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs. Int J Neuropsychopharmacol. 27:1-12.

B. Refereed Scientific Review Papers, Essays and Book Chapters

  1. Fink, G. (1968) Studies on luteinizing hormone releasing factor (LRF) in hypophysial portal blood of rats. In: Pharmacology of Hormonal Polypeptides and Proteins, pp 128-137. Eds. N. Beck, L. Martini & R. Paoletti, New York: Plenum Press.
  2. Fink, G. (1968) Discussion of hypothalamic releasing factors. In: The Investigation of Hypothalamic-Pituitary Adrenal Function, pp 17-18. Eds. V.H.T. James & J. Landon, London: Cambridge University Press.
  3. Fink, G. (1972) Neurones and hormones.  Nature 237 15 (invited review of conference on neuroendocrinology, Oxford 1972).
  4. Fink, G., Aiyer, M.S., Jamieson, M.G. & Chiappa, S.A. (1975) Factors modulating the responsiveness of the anterior pituitary gland to hypothalamic hormones in the rat with special reference to gonadotrophin releasing hormone (GnRH). In: Hypothalamic Hormones: Chemistry, Physiology, Pharmacology and Clinical Uses, pp 139-160. Eds. M. Motta, L. Martini & P.G. Crosignani, New York: Academic Press.
  5. Fink, G. (1976) The development of the releasing factor concept.  Clin. Endocrinol. 5 suppl 245‑260.
  6. Fink, G. (1976) Control of the ovarian cycle in the rat. In: Ovulation of the Human, pp 95-114. Eds. P.G. Crosignani & D.R. Mishell, New York: Academic Press.
  7. Fink, G. (1977) Inadvertent collaboration.  Nature 269 747-748. (Invited ‘News and Views’ article).
  8. Fink, G. (1977) The hypothalamic pituitary ovarian axis. In: Recent Advances in Obstetrics and Gynaecology, pp 3-54. Eds. J. Stallworthy & G. Bourne, 12th Edition. London: Churchill Livingstone.
  9. Fink, G., Chiappa, S.A., Pickering, A. & Sarkar, D. (1977) Control of rat oestrous cycle. In: Endocrinology, Vol 1, pp 186-191. Ed. V.H.T. James, Amsterdam – Oxford: Excerpta Medica.
  10. Fink, G. & Pickering, A.J.M.C. (1977) The hypothalamo-hypophysial system: window on central neurotransmission. In: Molecular Endocrinology, pp 293-308. Eds. I. MacIntyre & M. Szelke, Amsterdam: Elsevier.
  11. Szelke, M., Hudson, D., Sharpe, R., MacIntyre, I., Fink, G. & Pickering, A.M.C. (1977) Isoteric analogues of peptide hormones. In: Molecular Endocrinology, pp 57-70. Eds. I. MacIntyre & M. Szelke, Amsterdam: Elsevier.
  12. Hudson, D., MacIntyre, I., Sharpe, R., Szelke, M., Fink, G. & Kenner, G.W. (1977) The synthesis, assay and conformation of methionine enkephalin. In: Molecular Endocrinology, pp 269-277. Eds. I MacIntyre & M. Szelke, Amsterdam: Elsevier.
  13. Fink, G. & Geffen, L.B. (1978) The hypothalamo-hypophysial system: model for central peptidergic and monoaminergic transmission. In: International Review of Physiology, Neurophysiology III, Vol 17, pp 1-48. Ed. R. Porter, Baltimore: University Park Press.
  14. Fink, G. (1979) Feedback actions of target hormones on hypothalamus and pituitary with special reference to gonadal steroids.  Annu. Rev. Physiol. 41 571-585.
  15. Fink, G. (1979) Neuroendocrine control of gonadotrophin secretion.  Br. Med. Bull. 35 (2) 155‑160.
  16. Fink, G. & Pickering, A. (1980) Modulation of pituitary responsiveness to gonadotropin releasing hormone. In: Synthesis and Release of Adenohypophyseal Hormones, pp 617-638. Eds. M. Jutisz & K. McKerns, New York: Plenum Press.
  17. Fink, G. (1981) Has corticotropin-releasing factor finally been found. Nature 294 270-272. (Invited ‘News and Views’ article).
  18. Fink, G. (1981) Chemical phrenology of the hypothalamus: another illusion.  Nature 293 764 (Book Review).
  19. Fink, G., Aiyer, M., Chiappa, S., Henderson, S., Jamieson, M., Levy-Perez, V., Pickering, A., Sarkar, D., Sherwood, N., Speight, A. & Watts, A. (1982) Gonadotropin-releasing hormone: release into hypophyseal portal blood and mechanism of action. In: Hormonally Active Brain Peptides: Structure and Function, pp 397-426. Eds. K. McKerns & V. Pantic, New York: Plenum Press.
  20. MacInnes, D.G., Green, D.K., Harmar, A., Nairn, E.G. & Fink, G. (1983) Studies of neurotransmitter receptor interactions using quantitative video intensification microscopy (VIM). In: The Application of Laser Light Scattering to the Study of Biological Motion, pp 165-168. Eds. J.C. Earnshaw & M.W. Steer, New York: Plenum Publishing Corporation.
  21. Fink, G. (1983) Growth hormone releasing factor: a tale of two islets.  Nature 301 562. (Invited ‘News and Views’ article).
  22. Fink, G., Koch, Y. & Ben Aroya, N. (1983) TRH in hypophysial portal blood: characteristics of release and relationship to thyrotropin and prolactin secretion. In: Thyrotropin-Releasing Hormone, pp 127-143. Eds. E.C. Griffiths & G.W. Bennett, New York: Raven Press.
  23. Christie, J.E., Whalley, L.J., Dick, H. & Fink, G. (1983) Plasma cortisol concentrations in the functional psychoses and Alzheimer type dementia: a neuroendocrine day approach in drug-free patients. J. Steroid Biochem. 19 247-250.
  24. Fink, G., Stanley, H.F. & Watts, A.G. (1983) Central nervous control of sex and gonadotropin release: peptide and nonpeptide transmitter interactions. In: Brain Peptides, pp 413-435. Eds. D.T. Krieger, M.J. Brownstein & J.B. Martin, New York: John Wiley & Sons, Inc.
  25. Fink, G. (1984) Surge, pulse and diurnal generators in the hypothalamic-pituitary-gonadotrophin system. In: Oscillations in Physiological Systems: Dynamics and Control, pp 239-246. London: The Institute of Measurement and Control.
  26. Fink, G., Curtis, A. & Lyons, V. (1984) Regulation of the synthesis, release and action of hypothalamic luteinizing hormone releasing hormone. In: Hormonal Control of the Hypothalamo-Pituitary-Gonadal Axis, pp 89-100. Eds. K.W. McKerns & Z. Naor, New York: Plenum Publishing Corporation.
  27. Fink, G. (1984) Hypothalamic-pituitary-gonadal axis: concluding remarks. In: Hormonal Control of the Hypothalamo-Pituitary-Gonadal Axis, pp 603-610. Eds. K.W. McKerns & Z. Naor, New York: Plenum Publishing Corporation.
  28. Stanley, H.F. & Fink, G. (1984) Hypothalamic mRNA and its role in sexual differentiation. In: Endocrinology, pp 314-318. Eds. F. Labrie & L. Proulx, International Congress Series 655. Amsterdam: Excerpta Medica.
  29. Curtis, A., Lyons, V. & Fink, G. (1984) The LHRH precursor is the same size in human, rat and mouse hypothalamus. In: Endocrinology, pp 361-365. Eds. F. Labrie & L. Proulx, International Congress Series 655. Amsterdam: Excerpta Medica.
  30. Yates, C.M., Harmar, A.J., Sheward, W.J., Simpson, J., Rosie, R., Fink, G. & Gordon, A. (1985) Peptides and amines in Alzheimer-type dementia and Down’s syndrome. In: Interdisciplinary Topics in Gerontology, Vol 19, pp 175-183. Ed. H.P. von Hahn, Basel: Karger.
  31. Fink, G. (1985) Homeostasis and hormonal regulation (neuroendocrine reflections of the brain. In: Functions of the Brain, Wolfson Lecture, pp 130-159. Ed. C. Cohen, Oxford: Oxford University Press.
  32. Fink, G. (1985) Has the prolactin inhibiting peptide at last been found.  Nature 316 487-488. (Invited ‘News and Views’ article).
  33. Fink, G. (1986) Characteristics of neurohormone biosynthesis in the hypothalamus and release into hypophysial portal blood. In: Neuroendocrine Perspectives, 5, pp 23-34. Eds. E.E. Muller & R.M. MacLeod, Amsterdam: Elsevier Science Publishers BV.
  34. Fink, G. (1986) The endocrine control of ovulation. Sci. Prog. 70, 403-423.
  35. Curtis, A., Szelke, M. & Fink, G. (1986) Detection of a high-molecular-weight LHRH precursor by cell-free translation of mRNA from human, rat, and mouse hypothalamus. In: Neuroendocrine Peptides (Methods in Enzymology, 124, pp 318-335. Ed. P.M. Conn, Florida: Academic Press Inc.
  36. Yates, C.M., Harmar, A.J., Pierotti, A., Simpson, J., Fink, G., Bennie, J. & Gordon, A. (1986) Monoamines and peptides in ageing, Alzheimer-type dementia and Down’s syndrome. In: Psychiatric Disorders in the Elderly, pp 11-24. Eds. P.E. Bebbington & R. Jacoby, London: The Mental Health Foundation.
  37. Curtis, A., Rosie, R., Lyons, V. & Fink, G. (1986) The biosynthesis of LHRH. In: Neuroendocrine Molecular Biology, pp 85-90. Eds. G. Fink, A.J. Harmar & K.W. McKerns, New York: Plenum Press.
  38. Mitchell, R., Ogier, S-A., Johnson, M., Cleland, A., Bennie, J. & Fink, G. (1986) Evidence for sex differences in GnRH receptors and mechanism of action. In: Neuroendocrine Molecular Biology, pp 91-100. Eds. G. Fink, A.J. Harmar & K.W. McKerns, New York: Plenum Press.
  39. Morris, J.F., Lewis, C.E. & Fink, G. (1986) LHRH priming in gonadotrophs: a model system for the analysis of neuroendocrine mechanisms at the cellular level. In: Neuroendocrine Molecular Biology, pp 341-352. Eds. G. Fink, A.J. Harmar & K.W. McKerns, New York: Plenum Press.
  40. Christie, J.E., Whalley, L.J., Bennie, J., Dick, H., Blackwood, D.H.R. & Fink, G. (1986) Neuroendocrine changes in Alzheimer’s disease: raised plasma concentrations of growth hormone and thyroid stimulating hormone and reduced concentrations of oestrogen-stimulated neurophysin. In: Neuroendocrine Molecular Biology, pp 457-464. Eds. G. Fink, A.J. Harmar & K.W. McKerns, New York: Plenum Press.
  41. Fink, G. (1987) Highs and lows.  Book review (Drugs and the Brain by Solomon H Snyder).  Nature 325 671-672.
  42. Fink, G. (1987) Introduction: role of chemical neurotransmission in brain function. In: Basic and Clinical Aspects of Neuroscience: Transmitter Molecules in the Brain, pp 1-5. Eds. E. Fluckiger, E.E. Muller & M.O. Thorner, Heidelberg: Springer-Verlag.
  43. Fink, G. (1987) Normal and disordered central neurotransmitter function studied through the neuroendocrine window of the brain. In: Basic and Clinical Aspects of Neuroscience: Transmitter Molecules in the Brain, pp 55-74. Eds. E. Fluckiger, E.E. Muller & M.O. Thorner, Heidelberg: Springer-Verlag.
  44. Fink, G. (1987) Problems and prospects. In: Basic and Clinical Aspects of Neuroscience: Transmitter Molecules in the Brain, pp 75-78. Eds. E. Fluckiger, E.E. Muller & M.O. Thorner, Heidelberg: Springer-Verlag.
  45. Fink, G. (1988) Gonadotropin secretion and its control. In: The Physiology of Reproduction, 1 & 2, pp 1349-1377. Eds. E. Knobil, J. Neill et al, New York: Raven Press Ltd.
  46. Fink, G. (1988) The G W Harris lecture. Steroid control of brain and pituitary function. Q. J. Exp. Physiol. 73, 257-293.
  47. Fink, G. (1988) Oestrogen and progesterone interactions in the control of gonadotrophin and prolactin secretion. J. Steroid Biochem. 30, 169-178.
  48. Fink, G. & Sheward, W.J. (1989) Neuropeptide release in vivo: measurement in hypophysial portal blood. In: Neuropeptides: a Methodology, pp 157-188. Eds. G. Fink & A.J. Harmar, Chichester: John Wiley & Sons Ltd.
  49. Christie, J.E., Bennie, J., Kutcher, S., Hunter, R. & Fink, G. (1989) Neuroendocrine changes in dementia of Alzheimer type: towards a diagnostic marker system.  In: Proceedings of the Stistelsen Gamlia Tjanarinnor Symposium on Aging and Aging Disorder No 1.  Eds. C.J. Fowler, O.A. Carlson, C.-G. Gottfries & B. Winblad, London: Smith-Gordon & Co Ltd.
  50. Fink, G. (1990) Development aspects of the control of gonadotropin secretion before and during puberty. In: Control of the Onset of Puberty, pp 321-342. Eds. M.M. Grumbach, P.C. Sizonenko & M.L. Aubert, Williams & Wilkins.
  51. Christie, J.E., Fink, G. & Yates, C.M. (1990) Alzheimer’s disease. In: The Metabolic and Molecular Basis of Acquired Disease, Vol 2, pp 1411-1438. Eds. R.H. Cohen, B. Lewis, K.G.M.M. Alberti, & A.M. Denman, Baillière Tindall.
  52. Fink, G., Rosie, R. & Thomson, E. (1991) Steroid actions on hypothalamic neurons with special reference to estrogen control of luteinizing hormone-releasing hormone biosynthesis and release. In: Volume Transmission in the Brain: Novel mechanisms for Neural Transmission, pp 195-211. Eds. K. Fuxe & L.F. Agnati, New York: Raven Press Ltd.
  53. Fink, G., Rosie, R. & Thomson, E. (1991) Control of gonadotrophin secretion. In: Pituitary Adenomas: New Trends in Basic and Clinical Research, pp 19‑27. Eds. G. Faglia, P. Beck-Peccoz, B. Ambrosi, P. Travaglini & A. Spada, Amsterdam: Elsevier.
  54. Fink, G., Rosie, R. & Thomson, E. (1992) Steroid regulation of the biosynthesis and release of luteinizing hormone releasing hormone.  In: Hormones in Gynecological Endocrinology, pp 3-15. Eds. A.R. Genazzani & F. Petraglia, Lancs, UK: The Parthenon Publishing Group.
  55. Fink, G. (1992) A national primate centre? Nature 358 705. (Letter)
  56. Fink, G. (1993) A consideration of methodology. In: Corticotropin-releasing factor (Ciba Foundation Symposium 172), pp 199-203. Chichester: Wiley.
  57. Fink, G. (1994) Molecular principles from neuroendocrine models: steroid control of central neurotransmission.  Prog. Brain Res. 100: 139-147.
  58. Fink, G. (1995) The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms.  In: Serotonin in the Central Nervous System and Periphery (Takada, A & Curzon, G, eds), pp 175-187.  Amsterdam: Elsevier.
  59. Fink, G. (1996) The psychoprotective action of oestrogen is mediated by central 5-hydroxytryptamine as well as dopamine receptors.  In: Molecular Mechanisms of Neuronal Communication, pp177-204. Eds K. Fuxe, T HÖkfelt, L. Olson, D.Ottoson, A. DahlstrÖm & A, BjÖrklund. Oxford: Pergamon.
  60. Harmar, A. J., Ogilvie, A. D., Battersby, S., Smith, C. A. D., Blackwood, D. H. R., Muir, W. J., Fink, G. & Goodwin, G. M. (1996) The serotonin transporter gene and affective disorder.  In: Cold Spring Harbor Symposia on Quantitative Biology, Vol 61, pp791-795.
  61. Fink, G. (1997) Mechanisms of negative and positive feedback of steroids in the hypothalamic-pituitary system.  In: Principals of Medical Biology, Vol 10A, pp29-100 Eds E.E. Bittar & N. Bittar. Connecticut: JAI Press Inc.
  62. Fink, G. (1998) Wherein blue genes?  Book review of “Mood Genes: Hunting for Origins of Mania and Depression” by Samuel H. Barondes, Nature 393: 534-536.
  63. Antoni F.A., Smith, S.M., Simpson, J., Rosie, R., Fink, G., & Paterson, J.M. (1998) Calcium Control of Adenylyl Cyclase: The Calcineurin Connection.  In: Advances in Second Messenger and Phosphoprotein Research, Vol 32, pp153-172 Ed D.M.F. Cooper. Philadelphia: Lippincott-Raven.
  64. Fink, G. (2000) Endocrine Systems. In: Encyclopedia of Stress, Vol 2 pp 47 – 48, Ed-in-Chief  G Fink. San Diego: Academic Press.
  65. Fink, G. (2000) Feedback Systems. In: Encyclopedia of Stress, Vol 2 pp 124 – 137, Ed-in-Chief  G Fink. San Diego: Academic Press. (updated version in second edition, 2007).
  66. Fink, G. (2000) Neuroendocrine Systems. In: Encyclopedia of Stress, Vol 3 pp 14 – 31, Ed-in-Chief  G Fink. San Diego: Academic Press.(updated version in second edition,2007).
  67. Fink, G. (2000) Secretagogue. In: Encyclopedia of Stress, Vol 3 pp 409 – 411, Ed-in-Chief  G Fink. San Diego: Academic Press.
  68. Kulkarni J & Fink G (2000) Hormones and Psychosis. In : Women in Schizophrenia, pp 51-66, Eds DJ Castle, J McGrath and J Kulkarni. Cambridge: Cambridge University Press.
  69. Fink, G. (2009) Stress: Definition and History. In: Encyclopedia of Neuroscience, pp 549-555. Ed-in-Chief L Squire. Oxford: Elsevier Ltd
  70. Fink G. (2012) Neuroendocrine Feedback Control Systems: An Introduction. In: Fink G, Pfaff DW, Levine JE, eds. Handbook of Neuroendocrinology. London, Waltham, San Diego: Academic press, Elsevier;2012:55-72.
  71. Fink G. (2012) Neural Control of the Anterior Lobe of the Pituitary Gland (Pars Distalis). In: Fink G, Pfaff DW, Levine JE, eds. Handbook of Neuroendocrinology. London, Waltham, San Diego: Academic press, Elsevier; 2012:97-138.


C. Theses and Books

1.    Fink, G. (1967) Experimental studies on luteinizing hormone releasing factor in hypophysial portal blood.  Thesis for the degree of DPhil, University of Oxford.

2.    Fink, G. (1978) Neural-endocrine interactions.  Collection of papers submitted for the degree of MD, Melbourne University.

3.    Fink, G. & Whalley, L.J. Eds. (1982) Neuropeptides: Basic and Clinical Aspects. Proceedings of the eleventh Pfizer International Symposium, September 1981, Pp 1-286.  Edinburgh: Churchill Livingstone.

4.    Fink, G., Harmar, A.J. & McKerns, K.W. Eds. (1986) Neuroendocrine Molecular Biology, Pp 1-510. New York: Plenum.

5.    Fluckiger, E., Muller, E.E. & Thorner, M.O. Eds.  Organised by G. Fink (1987) Basic and Clinical Aspects of Neuroscience: Transmitter Molecules in the Brain, Vol 2, Pp 1-78. Heidelberg: Springer Verlag.

6.    Fink, G. & Harmar, A.J. Eds. (1989) Neuropeptides: A Methodology (IBRO Handbook Series: Methods in Neuroscience), pp 370. Chichester: John Wiley & Sons Ltd.

7.    Fink, G. Editor-in-Chief (2000) Encyclopedia of Stress, 3 vols, Pp 2328. San Diego, Academic Press – Awarded BMA 2001 commendation for contribution to Mental Health.

8.    Fink, G. Editor-in-Chief (2007) Encyclopedia of Stress, Second Edition, 4 vols. Pp 3000.  San Diego, Academic Press, Elsevier Ltd. Japanese edition published 2009.

9.    Fink, G. Editor (2009) Stress Science: Neuroendocrinology. Pp 829. San Diego, Academic Press, Elsevier Ltd.

10.  Fink, G. Editor (2009) Stress Consequences: Mental, Neuropsychological and Socioeconomic. Pp 780. San Diego, Academic Press, Elsevier Ltd.

11. Fink, G. Editor (2010) Stress of War, Conflict and Disaster. Pp 800. San Diego, Academic Press, Elsevier Ltd.

12. Fink G, Pfaff, DW, Levine JE (Eds.) (2011) Handbook of Neuroendocrinology. London, Waltham, San Diego: Academic Press, Elsevier.

 

D.  Scientific Abstracts and Short Notes

1.    Fink, G. (1964) Nerve fibres in deciduous and non-deciduous uteri. J. Anat. 98 486.

2.   Fink, G., Nallar, R. & Worthington, W.C. Jr. (1966) Determination of luteinizing hormone   releasing factor (LRF) in hypophysial portal blood. J. Physiol. 193 20‑21P.

3.    Fink, G. (1967) Further studies on luteinizing hormone releasing factor (LRF) in hypophysial portal blood of rats.  J. Physiol. 191 125-126P.

4.    Fink, G. (1969) The arrangement of long hypophysial portal veins in the rat.  J. Anat. 104 403.

5.    Fink, G., Lee, W.K. & Simpson, R.W. (1969) Dopamine and the secretion of adrenocorticotrophin.  Aust. J. Exp. Biol. Med. Sci. 47 9.

6.    Fink, G., Lee, W.K. & Burger, H.G. (1970) Luteinizing hormone releasing activity of an ultrafiltrate of rat hypophysial portal blood.  Proc. 13th Annual Meeting Endocr. Soc. Australia.

7.    Lee, W.K., Burger, H.G. & Fink, G. (1970) Radioimmunoassay of rat luteinizing hormone.  Proc. 13th Annual Meeting Endocr. Soc. Australia.

8.    Osborne, W., Smith, G.C. & Fink, G. (1970) Experimental studies on catecholamines in the median eminence and arcuate nucleus of rabbits.  J. Anat. 106 201.

9.    Fink, G. & Smith, G.C. (1971) Ultrastructural features of the prenatal development of the hypothalamo-pituitary axis in the rat.  J. Anat. 108 207.

10.  Fink, G. & Smith, G.C. (1971) The effect of hypothalamic lesions on the fluorescence histochemical and ultrastructural appearance of the rat median eminence.  J. Anat. 108 207.

11.  Augee, M., Fink, G. & Smith, G.C. (1971) Morphological and experimental studies on the pars distalis of the echidna (Tachyglossus aculeatus).  J. Anat. 108 208.

12.  Aiyer, M.S., Greig, F. & Fink, G. (1972) Changes in sensitivity of the anterior pituitary gland to synthetic luteinizing hormone releasing factor during the oestrous cycle of the rat.  J. Endocrinol. 57 xxvi.

13.  Aiyer, M.S., Fink, G. & Greig, G. (1973) Sensitivity of the anterior pituitary gland to luteinizing hormone releasing factor (LRF) during pro-oestrus.  J. Physiol. 231 32-34P.

14.  Aiyer, M.S., Chiappa, S.A., Fink, G. & Greig, F. (1973) A priming effect of luteinizing hormone releasing factor on the anterior pituitary gland of the female rat.  J. Physiol. 234 81-82P.

15. Jamieson, M.G., Fink, G. & Chiappa, S.A. (1973) An in vitro method for the assay of   luteinizing hormone releasing factor.  J. Endocrinol. 59 xi-xii.

16.  Aiyer, M.S., Chiappa, S.A. & Fink, G. (1974) Effect of ovarian steroids on pituitary sensitivity to luteinizing hormone releasing factor in the rat.  J. Endocrinol. 61 xii.

17.  Fink, G. & Jamieson, M.G. (1974) Effect of electrical stimulation of the pre-optic area on luteinizing hormone releasing factor in pituitary stalk blood.  J. Physiol. 237 37-38P.

18.  Fink, G., Greig, F., Chiappa, S. & Henderson, S.R. (1974) Peripheral plasma luteinizing hormone releasing factor and the spontaneous and reflex release of luteinizing hormone in the rat.  J. Endocrinol. 63 33-34P.

19.  Fink, G. & Jamieson, M.G. (1974) Effect of preoptic stimulation on luteinizing hormone releasing factor in pituitary stalk blood during oestrous cycle of the rat.  J. Physiol. 241 128-130P.

20.  Chiappa, S.A., Sherwood, N.M. & Fink, G. (1975) Effect of sex steroid hormones on the release of luteinizing hormone releasing factor into rat pituitary stalk blood by electrical stimulation of the medial preoptic area.  J. Endocrinol 67 37-38P.

21.  Fink, G., Hudson, D., MacIntyre, I., Pickering, A. & Szelke, M. (1975) Biological activities of some analogues of luteinizing hormone releasing hormone.  J. Endocrinol. 67 39-40P.

22.  Fink, G. & Pickering, A. (1975) Dependence of the priming effect of luteinizing hormone releasing factor (LRF) on RNA and protein synthesis.  J. Physiol. 252 73-75P.

23.  Henderson, S.R., Baker, C. & Fink, G. (1976) Effect of precise oestradiol-17ß exposure on the gonadotrophin response to luteinizing hormone releasing factor and the spontaneous secretion of luteinizing hormone in acutely and chronically ovariectomized rats.  J. Endocrinol. 69 1-2P.

24.  Chiappa, S.A., Fink, G. & Sherwood, N.M. (1976) Areas of female rat brain concerned with release of immunoreactive luteinizing hormone releasing factor (LRF).  J. Physiol. 256 119-120P.

25.  Fink, G., Sarkar, D.K. & Chiappa, S.A. (1977) Gonadotrophin releasing hormone surge during pro-oestrus: role of steroid hormones.  J. Endocrinol. 75 46-47P.

26.  Fink, G. & Sarkar, D.K. (1978) Mechanism of first surge of luteinizing hormone and vaginal opening in the normal rat, and effect of neonatal androgen.  J. Physiol. 282 34-35P.

27.  Fink, G. (1979) Paradox of steroid action: the spontaneous luteinizing hormone surge.  J. Endocrinol. 80 26P.

28.  Charlton, H.M., Fink, G. & Halpin, D.M.G. (1981) The effects of multiple injections of gonadotrophin-releasing hormone (GnRH) in the hypogonadal mouse.  J. Physiol. 320 106‑107P.

29.  Brar, A., Dockray, G.J., Dow, R.C. & Fink, G. (1981) Cholecystokinin in rat hypophysial portal vessel blood.  Neurosci. Lett. p S322.

30.  Dow, R.C., Fink, G., Grieve, G. & Mitchell, R. (1982) GABA-like substances in hypophysial portal blood.  J. Physiol. 330 88-89P.

31.  Fink, G., Fraser, H.M., Harmar, A.J. & Sheward, W.J. (1983) Thyrotropin-releasing hormone like immunoreactivity in rat hypophysial portal blood not confined to pGlu-His-Pro-NH2.  J. Physiol. 334 124P.

32.  Cash, J.D., Dow, R.C., Fink, G., Prowse, C.V. & Sheward, W.J. (1983) A pituitary-derived releasing factor for plasminogen activator controlled by the hypothalamus in the rat.  J. Physiol. 338 46-47P.

33.  Smith, G.C., Fink, G., Willis, G.L. & Copolov, D. (1983) Effects on prolactin, corticosterone and IR ß-endorphin of manipulation of median eminence catecholamines and of stress in decapitated or cannulated rats.  Neurosci. Lett. 14 S438.

34.  Fink, G., Prowse, C.V. & Dow, R.C. (1983) A hypothalamic pituitary system stimulates plasminogen activator in plasma.  Soc. Neurosci. Abstracts 9.

35.  Fink, G., Horn, A.M. & Robinson, I.C.A.F. (1984) Vasopressin and oxytocin in hypophysial portal blood.  J. Physiol. 346 124P.

36.  Fink, G., Fraser, H.M. & Sheward, W.J. (1984) Effect of passive immunization with anti-TRH serum on electrically stimulated release of prolactin and TSH in the male rat.  J. Physiol. 346 123P.

37.  Fink, G. (1984) The external layer of the median eminence: a neurovascular synapse. In: Abstracts of the Eighth European Neuroscience Congress, p S286.  Amsterdam: Elsevier

38.  Fink, G., Fraser, H.M. & Sheward, W.J. (1984) Release of TSH and prolactin in response to suckling in anaesthetized lactating rats passively immunized with anti-TRH serum.  J. Physiol. 357 98P.

39.  Fink, G. (1984) The surge and pulse generators for gonadotrophin release.  J. Anat. 139 715.

40.  Fink, G., Curtis, A., Lewis, C.E., Lyons, V. & Morris, J.F. (1985) Action of LHRH: the pluripotent decapeptide.  J. Endocrinol. (Suppl) 104 10.

41. Mitchell, R., Minaur, N.J., Johnson, M.S., Ogier, S-A. & Fink, G. (1986) LHRH rapidly   elicits an opening of membrane Ca2+ channels which is suppressed by protein kinase C.  Biochem. Soc. Trans. 15 139.

42.  Johnson, M.S., Mitchell, R. & Fink, G. (1986) Dual effects of protein kinase C on LH secretion from rat anterior pituitary gland.  Biochem. Soc. Trans. 15 137.

43.  Ogier, S-A., Mitchell, R. & Fink, G. (1986) High yield solubilisation of undernatured LHRH receptors from rat anterior pituitary gland.  Biochem. Soc. Trans. 15 138.

44.  Charlton, H.M., Fink, G., Mayes, C.R., McQueen, J.K. & Watts, A.G. (1986) The effects of hypothalamic grafts on the density of neurophysin II-immunoreactivity in the brains of hypogonadal mice.  J. Physiol. 381 41P.

45.  Fink, G., Johnson, M.S., Minaur, N.J., Mitchell, R. & Ogier, S-A. (1986) LHRH-induced 45Ca2+ influx into rat anterior pituitary tissue in vitro can be reduced by activation of protein kinase C.  J. Physiol. 381 44P.

46.  Dow, R.C., Fink, G., Robinson, I.C.A.F. & Tannahill, L.A. (1986) Corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) in hypophysial portal vessel blood.  J. Physiol. 382 42P.

47.  Mayes, C.R., Watts, A.G., McQueen, J.K., Fink, G. & Charlton, H.M. (1987) The distribution of neurophysin II immunoreactivity in the forebrain of normal and hypogonadal female mice.  J. Anat. 152 256.

48.  Lewis, C.E., Morris, J.F. & Fink, G. (1987) Functional and morphological development of pituitary gonadotrophs in female mice.  J. Anat. 152 256.

49.  Bicknell, R.J., Coombes, J.E., Fink, G., Russell, J.A. & Sheward, W.J. (1988) Effects of naloxone and long-term morphine administration on oxytocin release into hypophysial portal blood in urethane-anaesthetized rats.  J. Physiol. 401 35P.

50.  Fink, G. & Sheward, W.J. (1990) Glucocorticoid feedback and the secretion of CRF-41, vasopressin and oxytocin in long-term hypophysectomized rats anaesthetized with pentobarbitone.  Proceedings of the Physiological Society, 22-23 September 1989.  J. Physiol. 420 73P.

51.  Fink, G., Johnson, M.S. & Mitchell, R. (1990) Effects of protein kinase C inhibitors on the priming effect of LHRH in rat anterior pituitary glands in vitro.  Proceedings of the Physiological Society, 22-23 September 1989.  J. Physiol. 420 76P.

52.  Thomson, E., Rosie, R., Blum, M., Roberts, J.L. & Fink, G. (1990) Estrogen positive feedback reduces arcuate pro-opiomelanocortin mRNA.  Proceedings of the 2nd International Congress of Neuroendocrinology, 24-29 June 1990.  Neuroendocrinology 52 (Suppl) P3.17.

53.  Seckl, J., Dickson, K., Yates, C. & Fink, G. (1990) Corticosteroid receptor mRNA expression in human and rat hippocampus.  Proceedings of the 2nd International Congress of Neuroendocrinology, 24-29 June 1990.  Neuroendocrinology 52 (Suppl) P4.72.

54.  Seckl, J. & Fink, G. (1990) Regulation of hippocampal glucocorticoid and mineralocorticoid receptor mRNA expression by Serotonin.  In: Soc. Neurosci. Abstracts, Vol 16, Part 2, P977.  Washington, Society for Neuroscience.

55.  Yau, J.L.W., Dow, R.C., Fink, G. & Seckl, J. (1992) Medial septal lesions increase glucocorticoid receptor messenger RNA expression in the rat hippocampus in vivoJ. Physiol. 446 280P.

56.  Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Lim, A.T., Copolov, D.L., Bennie, J., Carroll, S. & Dick, H. (1992) Atrial natriuretic peptide (ANP) is a physiological inhibitor of adrenocorticotrophin (ACTH) secretion in the rat.  J. Physiol. 446 441P.

57.  MacEwan, D.J., Simpson, J., Mitchell, R., Johnson, M.S., Thomson, F.J. & Fink, G. (1992) Properties and [32P] phosphorylation targets of a novel form of protein kinase C in pituitary. Biochem. Soc. Trans. 20 133S.

58.  Ison, A.J., Johnson, M.S., Clegg, R.A., Connor, K., Fink, G. & Mitchell, R. (1993) A distinct form of protein kinase C is selectively expressed in pituitary. Abstracts Society for Neurosci. 19, 309.14.

59.  Bluthé, R.M., Suarez, S., Fink, G., Roques, B. & Dantzer, R. (1993) Social recognition in mice is modulated by androgen-dependent vasopressinergic and cholecystokininergic neurotransmission.  Abstracts Society for Neurosci. 19, 73.6.

60.  Sumner, B.E.H. and Fink, G. (1995) Oestradiol-17ß in its positive feedback mode significantly increases 5-HT2A receptor density in the frontal, cingulate and piriform cortex of the female rat.  J. Physiol483.P: 52P.

61.  Grahame, L., Sumner, B.E.H., Rosie, R. and Fink, G. (1995) The effect of 5-HT2A receptor antagonists on LHRH mRNA biosynthesis in the female rat.  J. Physiol. 483.P: 53P.

62.  Grace, O.C., Fink, G. and Quinn, J.P. (1995) Identification of candidate transcriptional regulators of AVP.  J. Endocrinol. 144S: P78.

63.  Fink, G. (1995) The psychoprotective action of oestrogen is mediated by central serotonergic as well as dopaminergic mechanisms.  J. Psychopharmacol. 9(S), A58, 229.

64.  Fink, G. (1995) Estrogen and cortisol: are they Nature’s psychoprotectants?  Jpn. J. Physiol. 45: S2, SL-3.

65.  Fink, G. (1996) Letter to the Editor.  The Endocrinologist No. 40, June 1996: 4-5.

66.  McQueen, J.K., Wilson, H., Dow, R.C. and Fink, G. (1996) Oestradiol-17ß increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain.  J. Physiol. 495.P: 114P.

67.  Fink, G., Dow, R.C., Sumner, B.E.H., Rosie, R., Grahame, L.M., Bennie, J. and Carroll, S. (1996) 5-Hydroxytryptamine2A receptor antagonists block the oestradiol-17ß-induced surge of luteinizing hormone-releasing hormone (LHRH) into hypophysial portal blood but do not affect LHRH synthesis.  J. Physiol. 495.P: 117P.

68.  Sumner, B.E.H. and Fink, G., (1997) Testosterone or estrogen increases 5-HT2A receptor density in male rate forebrain.  Abstracts Society for Neurosci. 27th Annual Meeting No. 385.24

69.  Fink, G., Sumner, B.E.H., McQueen, J.K., Wilson, H. and Rosie, R (1998) Central serotonin mechanisms affected by sex steroids; relevance for mood, mental state and memory.  J. Physiol. 509.P: 17S

70.  Shanks, E.A., Dutia, M.B., McQueen, J.K., Leng, G. and Fink, G. (1998) Effects of oestradiol‑17ß on the firing characteristics of presumed 5‑hydroxytryptamine (5‑HT) neurons in rat dorsal raphe nucleus.  J. Physiol. -509P: 91P

71. V. Lavie; A. Bar-Joseph; A. Weksler; Y. Berkovitch; G. Fink; A. Biegon Dexanabinol (HU-211) improves long-term outcome in rats subjected to transient focal brain ischemia. Program No. 285.10. 2000 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2000. Online.

72. A. Bar-Joseph; V. Lavie; Y. Berckovitch; A. Weksler; Y. Greinstein; G. Fink Dexanabinol: a functional and morphological neuroprotectant in transient mca occlusion in rats. Program No. 285.11. 2000 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2000. Online.

73. S.G. Kachalsky; G. Fink Dexanabinol inhibits NMDA-induced calcium influx into hippocampal cells in culture. Program No. 423.13. 2000 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2000. Online.

74. S. Meilin; A. Bar-Joseph; V. Lavie; Y. Grienstein; G. Fink Dexanabinol is neuroprotective in the MPTP model of parkinson’s disease. Program No. 199.13. 2001 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2001. Online.

75. A. Bar-Joseph; V. Lavie; Y. Berckovitch; A. Weksler; M. Azulay; Y. Grienstein; G. Fink Neuroprotection by PRS-211,095: assessed functionally and morphologically in transient mca occlusion in rats Program No. 209.5.  2001 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2001. Online.

76. E. Juettler1; G. Fink2; S. Prinz1; M. Schwaninger1* The neuroprotective cannabinoid-derivative dexanabinol is an inhibitor of NF. Program No. 496.6. 2001 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2001. Online.

77. V. Lavie, A. Bar-Joseph, R. Margalit, A. Garzon, N. Menashe, S. Amselem, G. Fink, D.E. Dar. Cannabinoid CB2 selective, PRS-211,096, reduces neurological deficit in experimental autoimmune encephalomyelitis (EAE) Program No. 196.1. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online.

78. S. Meilin, E. Oni, I. Lavon, T. Sheinin, A. Avraham, G. Efroni, V. Lavie, O. Greenberg, R. Elgamiel, A. Bar-Joseph, G. Fink. Dexanabinol and its analog PRS-211,092 inhibit lps-induced brain inflammation. Program No. 304.4. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online.

79. A.Bar-Joseph, V. Lavie, Y. Berckovitch, M. Azulay, A. Weksler, Y. Grienstein, A. Garzon, O. Greenberg, R. Elgamiel, S. Amselem, G. Fink. Neuroprotection by a dextrocannabinoid in a 3 hours therapeutic window: assessed functionally in transient MCA occlusion in rats. Program No. 391.2. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online

80. A.Avraham, G. Efroni, E. Oni-Biton, A. Bar-Joseph, Y. Berckovitch, M. Azulai, A. Garzon, R. Elgamiel, O. Greenberg, S. Amselem, G. Fink. Effect of the dextrocannabinoid PRS-211,092 on gene expression in brain ischemia induced by MCAo Program No. 391.3. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online.

81. G. Fink, A. Richstein, D.E. Dar, A. Garzon, A. Nudelman, N. Menashe, S. Amselem, A. Bar-Joseph. Novel cannabinoids are analgesics in noxious and neuropathic pain models. Program No. 453.11. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online.

82. D.E. Dar, A. Nudelman, O. Greenberg, B. Avidor, L. Golender, A. Bar-Joseph, V. Lavie, A. Garzon, G. Fink. Novel dextrocannabinoids: structure-activity relationships Program No. 640.17. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002. Online.

83. S. Meilin, A. Weksler, A. Richstein, Y. Berckovitch, B. Avidor, Y. Avihai, A. Bar-Joseph, G. Fink. The analgesic activity of CB2 selective cannabinoids in noxious, visceral and inflammatory pain models. Program No. 909.4. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2003. Online.

84. A. Bar-Joseph, G. Fink, A. Richstein, D.E. Dar, S. Amselem, A. Bar-Ilan, B. Avidor, A. Yacovan, S. Meilin, A. Weksler, Y. Berckovitch. PRS-211,375, a novel selective CB2 receptor agonist, demonstrates analgesic activity in several animal models. Program No. 909.5. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2003. Online.

85. S. Kusljic, G. Fink, M. Van den Buuse. Serotonin depletion in dorsal hippocampus in rats causes enhanced phencyclidine-induced locomotor hyperactivity and disruption of prepulse inhibition Program No. 796.12. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. Online.

86. A.M. Pereira, G. Fink, S. Sundram. Differential regulation of MAPK signaling by clozapine and haloperidol in cortical neurons Program No. 1023.2. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2005. Online.

87. A.M. Pereira, G. Fink, S. Sundram. A novel mechanism by which clozapine induces ERK1/2 activation in cortical neurons Program No. 94.26/005. 2006 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2006. Online.

88. A.M. Pereira, G. Fink, S. Sundram. Clozapine transactivates the EGF receptor to stimulate ERK in cortical neurons. A therapeutic target for refractory schizophrenia? 2007 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2007. Online.

89. A.M. Pereira, A. Sugiharto, G. Fink, S. Sundram. EGF receptor mediates clozapine induction of ERK1/2 signaling in prefrontal cortex and striatum: a novel antipsychotic drug mechanism. 2008 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2008. Online.

 

E. Patents (2000-2007): Inventor on following

1.      Novel Non-Psychotropic Cannabinoids WO 01/98289, Publication Date December 27, 2001.  US Patent 6,610,737 B1   Publication Date August 26, 2003

2.      Bicyclic CB2 Cannabinoid Receptor Ligands WO 03/063758 A2, Publication Date August 7, 2003.  PCT US 2005/0020544  Publication 2005

3.      Dexanabinol and Dexanabinol Analogs Regulate Inflammation Related Genes WO 03/077832  PCT/IL03/00223 Publication Date September 25, 2003

4.      Non-Psychotropic Cannabinoids for Prevention of Cognitive Impairment WO 2004 /021974 Publication Date March 18, 2004.